Ha Tay Pharmaceutical Stock

Equities

DHT

VN000000DHT3

Pharmaceuticals

End-of-day quote HANOI S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
40,400 VND +2.80% Intraday chart for Ha Tay Pharmaceutical +10.99% +75.65%
Dynamic Chart
Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Ha Tay Pharmaceutical JSC announced that it has received VND 180.6 billion in funding from ASKA Pharmaceutical Holdings Co.,Ltd. CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Ha Tay Pharmaceutical JSC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Ha Tay Pharmaceutical Jsc Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
ASKA Pharmaceutical Co., Ltd. acquired additional 20% stake in Ha Tay Pharmaceutical JSC. CI
More news
1 day+2.80%
1 week+10.99%
1 month+44.29%
3 months+45.32%
6 months+75.65%
Current year+75.65%
More quotes
1 week
38 200.00
Extreme 38200
41 000.00
1 month
27 400.00
Extreme 27400
41 000.00
Current year
22 900.00
Extreme 22900
41 000.00
1 year
18 107.14
Extreme 18107.1429
41 000.00
3 years
13 178.57
Extreme 13178.5714
41 000.00
5 years
10 714.29
Extreme 10714.2857
41 000.00
10 years
2 813.85
Extreme 2813.8528
41 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 95-04-30
Chairman 73 93-02-28
Director/Board Member - 16-02-29
Members of the board TitleAgeSince
Chairman 73 93-02-28
Chief Executive Officer 51 95-04-30
Corporate Officer/Principal 55 97-10-31
More insiders
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
More about the company